INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES |
journalArticle |
2015 |
Martelli, N.; Billaux, M.; Borget, I.; Pineau, J.; Prognon, P.; van den Brink, H. |
Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease |
journalArticle |
2018 |
Danlos, F. X.; Voisin, A. L.; Dyevre, V.; Michot, J. M.; Routier, E.; Taillade, L.; Champiat, S.; Aspeslagh, S.; Haroche, J.; Albiges, L.; Massard, C.; Girard, N.; Dalle, S.; Besse, B.; Laghouati, S.; Soria, J. C.; Mateus, C.; Robert, C.; Lanoy, E.; Marabelle, A.; Lambotte, O. |
A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer |
journalArticle |
2015 |
Rondeau, V.; Pignon, J. P.; Michiels, S.; Group, Mach-Nc collaborative |
Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei |
journalArticle |
2019 |
Benhaim, L.; Faron, M.; Gelli, M.; Sourrouille, I.; Honore, C.; Delhorme, J. B.; Elias, D.; Goere, D. |
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial |
journalArticle |
2016 |
Loi, S.; Dafni, U.; Karlis, D.; Polydoropoulou, V.; Young, B. M.; Willis, S.; Long, B.; de Azambuja, E.; Sotiriou, C.; Viale, G.; Ruschoff, J.; Piccart, M. J.; Dowsett, M.; Michiels, S.; Leyland-Jones, B. |
Designs of drug-combination phase I trials in oncology: a systematic review of the literature |
journalArticle |
2015 |
Riviere, M. K.; Le Tourneau, C.; Paoletti, X.; Dubois, F.; Zohar, S. |
Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival |
journalArticle |
2015 |
Kapetanakis, N. I.; Uzan, C.; Jimenez-Pailhes, A. S.; Gouy, S.; Bentivegna, E.; Morice, P.; Caron, O.; Gourzones-Dmitriev, C.; Le Teuff, G.; Busson, P. |
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al |
journalArticle |
2015 |
Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M. |
Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role? |
journalArticle |
2016 |
Ou, D.; Levy, A.; Blanchard, P.; Nguyen, F.; Garberis, I.; Casiraghi, O.; Scoazec, J. Y.; Janot, F.; Temam, S.; Deutsch, E.; Tao, Y. |
Assessing head and neck cancer patient preferences and expectations: A systematic review |
journalArticle |
2016 |
Blanchard, P.; Volk, R. J.; Ringash, J.; Peterson, S. K.; Hutcheson, K. A.; Frank, S. J. |
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials |
journalArticle |
2015 |
Doussau, A.; Thiebaut, R.; Geoerger, B.; Schoffski, P.; Floquet, A.; Le Deley, M. C.; Mathoulin-Pelissier, S.; Rizzo, E.; Fumoleau, P.; Le Tourneau, C.; Paoletti, X. |
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer |
journalArticle |
2019 |
Kothari, G.; Ost, P.; Cheung, P.; Blanchard, P.; Tree, A. C.; van As, N. J.; Lo, S. S.; Moghanaki, D.; Loblaw, A.; Siva, S. |
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973) |
journalArticle |
2018 |
Goéré, D.; Pignon, J. P.; Gelli, M.; Elias, D.; Benhaim, L.; Deschamps, F.; Caramella, C.; Boige, V.; Ducreux, M.; de Baere, T.; Malka, D. |
Mutation-Independent Activation of the Anaplastic Lymphoma Kinase in Neuroblastoma |
journalArticle |
2016 |
Regairaz, M.; Munier, F.; Sartelet, H.; Castaing, M.; Marty, V.; Renauleaud, C.; Doux, C.; Delbe, J.; Courty, J.; Fabre, M.; Ohta, S.; Vielh, P.; Michiels, S.; Valteau-Couanet, D.; Vassal, G. |
Looking Beyond the Numbers: Highlighting the Challenges of Population-Based Studies in Cancer Research |
journalArticle |
2016 |
Blanchard, P.; Garden, A. S. |
Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives |
journalArticle |
2015 |
Mirghani, H.; Amen, F.; Blanchard, P.; Moreau, F.; Guigay, J.; Hartl, D. M.; Lacau St Guily, J. |
Inflammatory bowel diseases activity in patients undergoing pelvic radiation therapy |
journalArticle |
2017 |
Annede, P.; Seisen, T.; Klotz, C.; Mazeron, R.; Maroun, P.; Petit, C.; Deutsch, E.; Bossi, A.; Haie-Meder, C.; Chargari, C.; Blanchard, P. |
Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed-unexposed study evaluating the clinical impact of the order of drug administration |
journalArticle |
2016 |
Dourthe, M. E.; Ternes, N.; Gajda, D.; Paci, A.; Dufour, C.; Benhamou, E.; Valteau-Couanet, D. |
Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial |
journalArticle |
2018 |
Lebellec, L.; Bertucci, F.; Tresch-Bruneel, E.; Ray-Coquard, I.; Le Cesne, A.; Bompas, E.; Blay, J. Y.; Italiano, A.; Mir, O.; Ryckewaert, T.; Toiron, Y.; Camoin, L.; Goncalves, A.; Penel, N.; Le Deley, M. C. |
Diagnosis of systemic inflammatory diseases among patients admitted for acute pericarditis with pericardial effusion |
journalArticle |
2017 |
Assayag, M.; Abbas, R.; Chanson, N.; Perozziello, A.; Ducrocq, G.; Alexandra, J. F.; Dossier, A.; Papo, T.; Sacre, K. |
Innovations for phase I dose-finding designs in pediatric oncology clinical trials |
journalArticle |
2016 |
Doussau, A.; Geoerger, B.; Jimenez, I.; Paoletti, X. |
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial |
journalArticle |
2015 |
Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M. |
Bayesian survival analysis in clinical trials: What methods are used in practice? |
journalArticle |
2017 |
Brard, C.; Le Teuff, G.; Le Deley, M. C.; Hampson, L. V. |
Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: A random forest survival approach |
journalArticle |
2019 |
Laas, E.; Hamy, A. S.; Michel, A. S.; Panchbhaya, N.; Faron, M.; Lam, T.; Carrez, S.; Pierga, J. Y.; Rouzier, R.; Lerebours, F.; Feron, J. G.; Reyal, F. |
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial |
journalArticle |
2016 |
Jovelet, C.; Ileana, E.; Le Deley, M. C.; Motte, N.; Rosellini, S.; Romero, A.; Lefebvre, C.; Pedrero, M.; Pata-Merci, N.; Droin, N.; Deloger, M.; Massard, C.; Hollebecque, A.; Ferte, C.; Boichard, A.; Postel-Vinay, S.; Ngo-Camus, M.; De Baere, T.; Vielh, P.; Scoazec, J. Y.; Vassal, G.; Eggermont, A.; Andre, F.; Soria, J. C.; Lacroix, L. |
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial |
journalArticle |
2018 |
Pannier, D.; Adenis, A.; Bogart, E.; Dansin, E.; Clisant-Delaine, S.; Decoupigny, E.; Lesoin, A.; Amela, E.; Ducornet, S.; Meurant, J. P.; Le Deley, M. C.; Penel, N. |
Value of a short-term imaging follow-up after a benign result in a one-stop breast unit: Is it still useful? |
journalArticle |
2017 |
Daroles, J.; Borget, I.; Suciu, V.; Mazouni, C.; Delaloge, S.; Balleyguier, C. |
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma |
journalArticle |
2015 |
Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E. |
Phase I trial of bortezomib daily dose: safety, pharmacokinetic profile, biological effects and early clinical evaluation in patients with advanced solid tumors |
journalArticle |
2018 |
Bahleda, R.; Le Deley, M. C.; Bernard, A.; Chaturvedi, S.; Hanley, M.; Poterie, A.; Gazzah, A.; Varga, A.; Touat, M.; Deutsch, E.; Massard, C.; Van De Velde, H.; Hollebecque, A.; Sallansonnet-Froment, M.; Ricard, D.; Taillia, H.; Angevin, E.; Ribrag, V.; Soria, J. C. |
[Individualization of dose and fractionation of radiotherapy for head and neck cancers] |
journalArticle |
2019 |
Blanchard, P.; Biau, J.; Castelli, J.; Tao, Y.; Graff, P.; Nguyen, F. |
Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells |
journalArticle |
2016 |
Mittal, D.; Caramia, F.; Michiels, S.; Joensuu, H.; Kellokumpu-Lehtinen, P. L.; Sotiriou, C.; Loi, S.; Smyth, M. J. |
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology |
journalArticle |
2018 |
Texier, M.; Rotolo, F.; Ducreux, M.; Bouché, O.; Pignon, J. P.; Michiels, S. |
LONG-TERM SURVIVAL IN PATIENTS RESPONDING TO ANTI-PD-1/PD-L1 THERAPY AND DISEASE OUTCOME UPON TREATMENT DISCONTINUATION |
journalArticle |
2018 |
Gauci, M. L.; Lanoy, E.; Champiat, S.; Caramella, C.; Ammari, S.; Aspeslagh, S.; Varga, A.; Baldini, C.; Bahleda, R.; Gazzah, A.; Michot, J. M.; Postel-Vinay, S.; Angevin, E.; Ribrag, V.; Hollebecque, A.; Soria, J. C.; Robert, C.; Massard, C.; Marabelle, A. |
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies |
journalArticle |
2016 |
Postel-Vinay, S.; Aspeslagh, S.; Lanoy, E.; Robert, C.; Soria, J. C.; Marabelle, A. |
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial |
journalArticle |
2016 |
Blanchard, P.; Faivre, L.; Lesaunier, F.; Salem, N.; Mesgouez-Nebout, N.; Deniau-Alexandre, E.; Rolland, F.; Ferrero, J. M.; Houede, N.; Mourey, L.; Theodore, C.; Krakowski, I.; Berdah, J. F.; Baciuchka, M.; Laguerre, B.; Davin, J. L.; Habibian, M.; Culine, S.; Laplanche, A.; Fizazi, K. |
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead |
journalArticle |
2015 |
Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C. |
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials) |
journalArticle |
2015 |
Gourgou-Bourgade, S.; Cameron, D.; Poortmans, P.; Asselain, B.; Azria, D.; Cardoso, F.; A'Hern, R.; Bliss, J.; Bogaerts, J.; Bonnefoi, H.; Brain, E.; Cardoso, M. J.; Chibaudel, B.; Coleman, R.; Cufer, T.; Dal Lago, L.; Dalenc, F.; De Azambuja, E.; Debled, M.; Delaloge, S.; Filleron, T.; Gligorov, J.; Gutowski, M.; Jacot, W.; Kirkove, C.; MacGrogan, G.; Michiels, S.; Negreiros, I.; Offersen, B. V.; Penault Llorca, F.; Pruneri, G.; Roche, H.; Russell, N. S.; Schmitt, F.; Servent, V.; Thürlimann, B.; Untch, M.; van der Hage, J. A.; van Tienhoven, G.; Wildiers, H.; Yarnold, J.; Bonnetain, F.; Mathoulin-Pélissier, S.; Bellera, C.; Dabakuyo-Yonli, T. S. |
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment |
journalArticle |
2017 |
Annede, P.; Gouy, S.; Mazeron, R.; Bentivegna, E.; Maroun, P.; Petit, C.; Dumas, I.; Leary, A.; Genestie, C.; Lhomme, C.; Deutsch, E.; Morice, P.; Pautier, P.; Haie-Meder, C.; Chargari, C. |
Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients |
journalArticle |
2016 |
Deutsch, E.; Haie-Meder, C.; Bayar, M. A.; Mondini, M.; Laporte, M.; Mazeron, R.; Adam, J.; Varga, A.; Vassal, G.; Magne, N.; Chargari, C.; Lanoy, E.; Pautier, P.; Levy, A.; Soria, J. C. |
Proton versus photon radiation-induced cell death in head and neck cancer cells |
journalArticle |
2019 |
Wang, L.; Han, S.; Zhu, J.; Wang, X.; Li, Y.; Wang, Z.; Lin, E.; Wang, X.; Molkentine, D. P.; Blanchard, P.; Yang, Y.; Zhang, R.; Sahoo, N.; Gillin, M.; Zhu, X. R.; Zhang, X.; Myers, J. N.; Frank, S. J. |